NMC
RGLS

NEA Management Company’s Regulus Therapeutics RGLS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-6,467,802
Closed -$11.3M 36
2025
Q1
$11.3M Hold
6,467,802
0.87% 22
2024
Q4
$10.2M Hold
6,467,802
0.58% 24
2024
Q3
$10.2M Hold
6,467,802
0.55% 27
2024
Q2
$11.6M Hold
6,467,802
0.87% 22
2024
Q1
$18.6M Buy
6,467,802
+4,522,223
+232% +$13M 1.16% 24
2023
Q4
$2.49M Hold
1,945,579
0.17% 38
2023
Q3
$2.67M Hold
1,945,579
0.21% 36
2023
Q2
$2.86M Buy
1,945,579
+500,465
+35% +$736K 0.22% 37
2023
Q1
$1.22M Hold
1,445,114
0.08% 42
2022
Q4
$1.98M Sell
1,445,114
-1
-0% -$1 0.11% 49
2022
Q3
$2.46M Hold
1,445,115
0.12% 50
2022
Q2
$2.99M Sell
1,445,115
-13,006,032
-90% -$26.9M 0.15% 51
2022
Q1
$4.31M Buy
14,451,147
+8,000,091
+124% +$2.38M 0.12% 52
2021
Q4
$2.06M Hold
6,451,056
0.04% 54
2021
Q3
$4.46M Hold
6,451,056
0.05% 57
2021
Q2
$5.23M Hold
6,451,056
0.07% 57
2021
Q1
$10.1M Hold
6,451,056
0.23% 50
2020
Q4
$8.71M Buy
6,451,056
+4,398,601
+214% +$5.94M 0.23% 47
2020
Q3
$1.06M Hold
2,052,455
0.04% 50
2020
Q2
$1.4M Hold
2,052,455
0.06% 43
2020
Q1
$946K Hold
2,052,455
0.05% 46
2019
Q4
$1.83M Hold
2,052,455
0.09% 43
2019
Q3
$1.48M Hold
2,052,455
0.12% 41
2019
Q2
$2.57M Buy
2,052,455
+1,136,704
+124% +$1.42M 0.18% 37
2019
Q1
$934K Hold
915,751
0.05% 45
2018
Q4
$852K Sell
915,751
-10,073,259
-92% -$9.37M 0.03% 44
2018
Q3
$26M Sell
10,989,010
-900
-0% -$2.13K 1.12% 21
2018
Q2
$7.24M Hold
10,989,910
0.34% 37
2018
Q1
$7.89M Hold
10,989,910
0.35% 35
2017
Q4
$11.4M Hold
10,989,910
0.47% 29
2017
Q3
$13.7M Buy
+10,989,910
New +$13.7M 0.48% 25